Globe Life Inc. 4.25% Junior Su · GL-PD · FY2026 Q2 · Calendar Q3 2026

Globe Life raises 2026 EPS outlook as premiums and margins improve

The quarter supports a constructive operating trajectory: premium growth, higher expected life margins and raised EPS guidance outweighed near-term concerns around health claims, direct-to-consumer demand and execution of the Bermuda strategy.

Reported After market closeNYSEFinancial Services $12.87B market cap
85quality score

Earnings scorecard

Reported versus consensus
Reported EPS $3.61 Consensus $3.67
EPS surprise -1.6% Reported versus consensus
Reported revenue $1.60B Consensus $1.59B
Revenue surprise +0.6% Reported versus consensus

Market reaction

unavailable
Stock move — Event window
SPY move — Same window
Abnormal move — Stock minus SPY
Volume — Versus trailing sessions
Subsequent drift — Up to 20 sessions
Price and volume data were unavailable at publication time.

Ask FN2 about GL-PD FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior quarter, Globe Life reported stronger Q2 premium growth, raised 2026 EPS guidance, increased planned share repurchases, and broadened its AI initiatives. Management also clarified that Bermuda reinsurance is not expected to provide capital benefits until 2027, while highlighting new risks from AI-driven search and higher health obligations.

Guidance delta

Management raised 2026 EPS guidance to $15.55-$15.95, citing higher life margins, premium growth and modest remeasurement gains.

Key takeaways

  • Q2 net income increased 20% year over year; life premium revenue rose 7% and health premium revenue rose 16%.
  • Management expects life underwriting margin to exceed 50% in Q3 after assumption updates.
  • The company expanded planned 2026 share repurchases to $670-$700 million and is applying AI across claims, underwriting and sales.

Management priorities

  • Expand AI applications across claims, underwriting and agent training.
  • Support agent recruitment and retention through compensation adjustments.
  • Complete the Bermuda reinsurance cession and pursue reciprocal-jurisdiction approvals.

Follow GL-PD with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Company context

Snapshot as of publication

Founded in 1979 and based in McKinney, Texas, Globe Life Inc. (formerly Torchmark Corporation until its name change in August 2019) provides an array of life and supplemental health insurance products, alongside annuities, to lower-to-middle-income households across the United States through its various subsidiaries. The company's operations are divided into four primary segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its product offerings include whole life, term life, and other life insurance options; supplemental health coverage such as Medicare supplement, critical illness, and accident plans; and both single-premium and flexible-premium deferred annuities.

Historical context

All GL-PD earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the GL-PD recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-07-23T17:04:42.495836+00:00
  2. FN2 earnings calendar · 2026-08-27T01:23:13.912278+00:00
  3. Polygon adjusted daily market bars

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-23. For educational purposes only; not investment advice.